The Gubra Blog

Skeletal muscle histology reveals what muscle weight, body composition, and functional testing cannot: how muscle tissue is structured, maintained, and altered at the cellular level.

Read about how anti-obesity therapeutics in 2026 reflect a clear transition beyond first-generation incretin-based therapies.

Explore how we perform estrous cycling to determine the estrous cycle stage of our women’s health animal models.

With whole-brain spatial imaging, teams can move from selected sections to atlas-aligned, brain-wide endpoints that support more confident decisions in neurodegenerative disease research.

Explore how Gubra supports preclinical BBB studies that integrate CNS drug delivery with spatial characterization of disease biology.

Explore how AI-driven image analysis can enhance the evaluation of complex lung pathology and support more precise, quantitative readouts in fibrosis research.

In this article, we explore how AI-based scoring and quantitative image analysis are advancing preclinical kidney pathology.

What is in vivo pharmacology, and why is it essential in drug development? This article explains how in vivo pharmacology studies support preclinical research,

Preclinical histology work can greatly accelerate drug development and IND filings for final FDA approval. Read more about Gubra's preclinical histology services here.

As the drug development landscape evolves, the need for reliable and translational preclinical MASH models has never been greater.

The efficacy of an anti-atherosclerotic compound is only as good as the method used to measure it. Explore the difference between the DIO-LDLR-KO mouse model and the DIO-AAV-PCSK9 mouse model.

Explore a broad portfolio of robust and translational renal fibrosis models that are essential for evaluating the efficacy of new drug candidates.

In this article, we dive deeper into c-Fos, its function, and how it can be used in research.

We highlight the need for better preclinical models tailored to female biology and beyond.

At Gubra, AI helps us move faster and think broader — from tech scouting to data interpretation — always grounded in scientific expertise and real-world impact.

AI is reshaping peptide-based drug discovery by enabling rapid design, activity prediction, and optimization of novel therapeutics.

GubraView offers advanced visualization and quantification tools that allow researchers to assess and evaluate histological and imaging data more efficiently and accurately.

Read what makes Gubra's ReninAAV UNx dbdb mouse model one of the most reliable and translatable options available.

Leverage Gubra’s expertise in both obesity and 3D imaging.

Discover the critical role of preclinical CROs in drug development.

Selecting a CRO (contract research organization) is an important step in any pharmaceutical or biotechnology company’s preclinical development.